Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
98.8545682
Mar.Cap(Rs.Cr)
46,727.27
P/E
55.18
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Balance Sheet
ParticularsMar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
SOURCES OF FUNDS :      
Share Capital 169.41169.41169.41169.41169.41169.41
Reserves Total 1614.691583.592508.211327.711670.631973.01
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1784.101753.002677.621497.121840.042142.42
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 18.6715.5420.0834.630.180.58
Total Debt18.6715.5420.0834.630.180.58
Other Liabilities246.30254.22263.00260.29289.39315.72
Total Liabilities2049.072022.762960.701792.042129.612458.72
APPLICATION OF FUNDS :      
Gross Block 665.51635.93593.89602.891454.59561.30
Less : Accumulated Depreciation 344.26305.99263.26216.00696.53129.69
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 321.25329.94330.63386.89758.06431.61
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress13.9320.3130.5013.21120.121002.64
Producing Properties0.000.000.000.000.000.00
Investments 837.72542.78390.0924.4924.4924.55
Current Assets, Loans & Advances      
Inventories 514.30437.70512.71523.34483.03486.49
Sundry Debtors 222.06192.38205.24215.6099.80120.49
Cash and Bank Balance1061.201150.732479.111157.681066.411155.33
Loans and Advances 155.08167.62108.05274.71107.54228.87
Total Current Assets1952.621948.433305.122171.331756.781991.18
Less : Current Liabilities and Provisions      
Current Liabilities 806.64590.941046.53866.70559.871205.15
Provisions 692.10713.99615.36438.35442.04245.32
Total Current Liabilities & Provisions1498.741304.941661.901305.051001.921450.47
Net Current Assets453.88643.491643.22866.28754.86540.71
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets163.08151.38131.67117.24126.0984.60
Deferred Tax Liability17.1418.2018.8915.5717.2424.12
Net Deferred Tax145.94133.18112.78101.67108.8560.48
Other Assets276.33353.06453.48399.49363.22398.72
Total Assets2049.052022.762960.701792.032129.602458.71
Contingent Liabilities375.40350.59351.10485.78471.42512.80
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)